<table border="single" id="id_50d5dc01-1d89-4472-bd7c-16f8b3aaa78b" width="497.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="33.8%"></col>
<col width="34.4%"></col>
<col width="31.8%"></col>
<tbody>
<tr id="id_992d61d2-f590-4249-93d1-1065d0982c01">
<td align="left" stylecode="Botrule Toprule Rrule Lrule" valign="top">
<paragraph>Dihydropyridine Calcium Channel Blockers </paragraph>(CYP3A4 Inhibition) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<content stylecode="italics">In Vitro</content> Studies Demonstrated Potential for Voriconazole to Inhibit Metabolism (Increased Plasma Exposure) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">Frequent monitoring for adverse events and toxicity related to calcium channel blockers. Adjustment of calcium channel blocker dosage may be needed. </td>
</tr>
<tr id="id_217556e6-6baf-48c8-9db3-7098cb568875">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Sulfonylurea Oral Hypoglycemics (CYP2C9 Inhibition) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">Not Studied <content stylecode="italics">In Vivo</content> or <content stylecode="italics">In Vitro</content>, but Drug Plasma Exposure Likely to be Increased </td>
<td align="center" stylecode="Botrule Rrule" valign="top">Frequent monitoring of blood glucose and for signs and symptoms of hypoglycemia. Adjustment of oral hypoglycemic drug dosage may be needed. </td>
</tr>
<tr id="id_2b6d0d18-105d-4039-850c-e54cb21a0249">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>Vinca Alkaloids </paragraph>(CYP3A4 Inhibition) </td>
<td align="center" stylecode="Rrule" valign="top">Not Studied <content stylecode="italics">In Vivo</content> or <content stylecode="italics">In Vitro</content>, but Drug Plasma Exposure Likely to be Increased </td>
<td align="center" stylecode="Botrule Rrule" valign="top">Frequent monitoring for adverse events and toxicity (i.e., neurotoxicity) related to vinca alkaloids. Adjustment of vinca alkaloid dosage may be needed. </td>
</tr>
</tbody>
</table>